The HECAM Editorial Policy Committee recognizes as author/s of a manuscript those who register the following participation codes: The HECAM Editorial Policy Committee recognizes as author/s of a manuscript those who register the following participation codes:

1. a) Concept and Design
2. b) Collection of Data and Obtaining of results
3. c) Analysis and Interpretation of Data
4. d) Writing of the Manuscript
5. e) Critical Revision of the Manuscript
6. f) Approval of the Final Version
7. g) Patient Study Material
8. h) Identification of Funding Sources
9. i) Acknowledgement of Contributors
10. j) Adherence to Journal/Publisher Guidelines
11. k) Ethical Approval and Consent
12. l) Transparency in Methodology
13. m) Data Sharing and Accessibility
14. n) Declaration of Competing Interests
15. o) Compliance with Reporting Standards (CONSORT, PRISMA, etc.)
16. p) Statistical Counselling
17. q) Technical or Administrative Advice
18. r) Accountability for the Work (ICMJE)
19. s) Other Contributions (define)

Collaborators

Collaborators who do not comply with the participation codes indicated to be recognized as authors should not appear as such, but may be recognized in the acknowledgments, for example: those who acquire the funds; general supervision of the research group; technical editing; translation or correction of the written part; proofs, or other contributions to be specified.

Responsibilities of authors, reviewers, and editors

Authors, reviewers, and editors have the obligation to disclose the existence of personal, financial, institutional, family, intellectual, economic, academic, or corporate interest relationships, etc., that could affect scientific judgment, bias its conclusions, and influence the development of the manuscript or its review.

Conflicts of interest

Authors, reviewers, and editors have the obligation to declare the existence of personal, financial, institutional, family, intellectual, or academic, or corporate interest relationships, etc., that could affect scientific judgment, bias its conclusions, and influence the development of the manuscript or its review. All submitted manuscripts will include the “conflict of interest” section with the phrase: “The authors reported not having any personal, financial, institutional, family, intellectual, economic, academic, or corporate interest conflicts.” Authors who work for or receive sponsorship from pharmaceutical companies or other commercial organizations should declare this in this section; if there are conflicts of interest, the reason should be stated.